Blar i ODA Open Digital Archive på forfatter "Botteri, Edoardo"

Viser treff 1-4 av 4

    • Breast cancer mortality after implementation of organized population-based breast cancer screening in Norway. 

      Sebuødegård, Sofie; Botteri, Edoardo; Hofvind, Solveig (Journal of the National Cancer Institute;, Journal article; Peer reviewed, 2019)
      Background We estimated breast cancer (BC) mortality reduction associated with invitations to a nation-wide population based screening program and changes in treatment, in Norway. Material and methods BreastScreen ...

    • The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants 

      Kværner, Ane Sørlie; Birkeland, Einar Elvbakken; Bucher-Johannessen, Cecilie; Vinberg, Elina; Nordby, Jan Inge; Kangas, Harri; Bemanian, Vahid; Ellonen, Pekka; Botteri, Edoardo; Natvig, Erik; Rognes, Torbjørn; Hovig, Eivind; Lyle, Robert; Ambur, Ole Herman; de Vos, Willem M.; Bultman, Scott J; Hjartåker, Anette; Landberg, Rikard; Song, Mingyang; Blix, Hege Salvesen; Ursin, Giske; Randel, Kristin Ranheim; de Lange, Thomas; Hoff, Geir; Holme, Øyvind; Berstad, Paula; Rounge, Trine Ballestad (BMC Cancer;21, Article number: 930 (2021), Peer reviewed; Journal article, 2021-08-18)
      Background: Colorectal cancer (CRC) screening reduces CRC incidence and mortality. However, current screening methods are either hampered by invasiveness or suboptimal performance, limiting their effectiveness as primary ...

    • Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway. 

      Botteri, Edoardo; Støer, Nathalie Charlotte; Sakshaug, Solveig; Graff-Iversen, Sidsel; Vangen, Siri; Hofvind, Solveig; de Lange, Thomas; Bagnardi, Vincenzo; Ursin, Giske; Weiderpass, Elisabete (BMJ Open;Volume 7, Issue 11, Journal article; Peer reviewed, 2017-11-15)
      Objectives: With the present study, we aimed to investigate the association between menopausal hormone therapy (HT) and risk of colorectal cancer (CRC). Setting: Cohort study based on the linkage of Norwegian population-based ...

    • Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role? 

      Botteri, Edoardo; Støer, Nathalie; Sakshaug, Solveig; Graff-Iversen, Sidsel; Vangen, Siri; Hofvind, Solveig; Ursin, Giske; Weiderpass, Elisabete (International Journal of Cancer;Volume 141, Issue 9, Journal article; Peer reviewed, 2017-11-01)
      The association between use of menopausal hormone therapy (HT) and occurrence of skin malignant melanoma (SMM) is controversial. We investigated the issue in a nationwide cohort of 684,696 Norwegian women, aged 45-79 ...